Transient thrombotic state after abrupt discontinuation of heparin in percutaneous coronary angioplasty

American Heart Journal

Volumn 131, Issue 3, 1996, Pages 434-439

  Conrad Smith, A J ^b   Holt, Robert E ^b   Fitzpatrick, Kelly ^b   Palacios, Igor F ^b   Gold, Herman K ^b   Werner, Wendy ^b   Bovill, Edwin G ^b   Fuster, Valentin ^b   Jang, Ik Kyung ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 9; FIBRINOPEPTIDE A; HEPARIN; POLYPEPTIDE;

ADULT; AGED; ARTICLE; BLOOD CLOTTING; CLINICAL ARTICLE; CORONARY ARTERY DILATATION; ELECTROCARDIOGRAM; FEMALE; HOLTER MONITORING; HUMAN; MALE; PRIORITY JOURNAL; REBOUND; THROMBOGENESIS; THROMBOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY; UNSTABLE ANGINA PECTORIS;

EID: 13344269686     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8703(96)90520-7     Document Type: Article

References (20)

1. Falk E. Plaque rupture with severe preexisting stenosis precipitating coronary thrombosis: characteristics of coronary atherosclerotic plaques underlying fatal occlusive thrombi. Br Heart J 1983;50:127-34.
2. Davies MJ, Thomas AC. Plaque fissuring: the cause of acute myocardial infarction, sudden ischemic death, and crescendo angina. Br Heart J 1985;53:363-73.
3. Theroux P, Waters D, Lam J, Juneau M, McCans J. Reactivation of unstable angina after the discontinuation of heparin. N Engl J Med 1992;327:141-5.
4. Gold HK, Torres FW, Garabedian HD, Werner W, Jang IK, Khan A, Hagstrom JN, Yasuda T, Leinbach RC, Newell JB, Bovill EG, Stump DC, Collen D. Evidence for a rebound coagulation phenomenon after cessation of a 4 hour infusion of a specific thrombin inhibitor in patients with unstable angina. J Am Coll Cardiol 1993;21:1039-47.
5. Waller BF. Pathology of transluminal balloon angioplasty used in treatment of coronary disease. Hum Pathol 1987;18:476-84.
6. Block PC, Myler RK, Startzer S, Fallon JT. Morphology after transluminal angioplasty in human beings. N Engl J Med 1981;305:382-5.
7. Mizuno K, Jurita A, Imazeki N. Pathologic findings after percutaneous transluminal coronary angioplasty. Br Heart J 1984;52:588-90.
8. Bauer KA, Rosenburg RD. The pathophysiology of the prethrombotic state in humans: insight gained from studies using markers of hemostatic system activation. Blood 1987;70:343-50.
9. Eisenberg PR, Sherman LA, Schectman K, Perez J, Sobel BE, Jaffe AS. Fibrinopeptide A: a marker of acute coronary thrombosis. Circulation 1985;71:912-8.
10. Mombelli G, Im Hof V, Haegerli A, Straub P. Effect of heparin on plasma fibrinopeptide A in patients with acute myocardial infarction. Circulation 1984;69:684-9.
11. Serneri G, Gensini G, Carnovali M, Prisco D, Rogasi PG, Casolo GC, Fazi A, Abbate R. Association between time of increased fibrinopeptide A levels in plasma and episodes of spontaneous angina: a controlled prospective study. AM HEART J 1987;113:672-8.
12. Theroux P, Latour JG, Leger-Gauthiuer C, De Lora J. Fibrinopeptide A and platelets factor levels in unstable angina pectoris. Circulation 1987;75:156-62.
13. Contant G, Gouault-Heilmann M, Martinoli JL. Heparin inactivation during blood storage: its prevention by blood collection in citric acid, theophylline, adenosine, dipyridamole-C.T.A.D. mixture. Thromb Res 1983;31:365-74.
14. Bock RD. Multivariate statistical methods in behavioral research. New York: McGraw-Hill, 1975:267.
15. Fuster V, Badimon L, Cohen M, Ambrose JA, Badimon JJ, Chesebro J. Insights into the pathogenesis of acute ischemic syndromes. Circulation 1988;77:1213-20.
16. Walford GD, Midei MA, Aversano TR, Gottlieb SO, Chew PH, Siu CO, Brin KP, Brinker JA. Heparin after PTCA: increased early complications and no clinical benefit (abstract). Circulation 1991;84:II-592.
17. Gabliani G, Deligonal U, Kern M, Vandormael M. Acute coronary occlusion occurring after successful percutaneous coronary angioplasty: temporal relationship to discontinuation of anticoagulation. AM HEART J 1988;116:696-700.
18. Marciniak E, Romond E. Catabolism and distribution of functionally heterogenous human antithrombin III. J Lab and Clin Med 1987;109:89-96.
19. Gailani D, Broze G Jr. Factor XIa activation in a revised model of blood coagulation. Science 1991;253:909-12.
20. Naito K, Fujikawa K. Activation of human blood coagulation factor XI independent of factor XII. J Biol Chem 1991;12:7353-8.1